Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for PROTAGONIST THERAPEUTICS INC COMMON STOCK (PTGX).
- Disclosed ownership: 5.2%.
- Date of event: 30 Jun 2025.
STATE STREET CORP - 30 Jun 2025 SCHEDULE 13G Report for PROTAGONIST THERAPEUTICS INC COMMON STOCK (PTGX)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- PTGX
- Shares outstanding
- 61,687,962 shares
- Disclosed Ownership
- 3,207,774 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Aug 2025, 08:04:05 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 13 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 5.2% ownership in PROTAGONIST THERAPEUTICS INC COMMON STOCK (PTGX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 13 May 2025.
- Current filing was accepted on 11 Aug 2025, 08:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 5.2% | 3,207,774 | 0 | 3,033,685 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |